s a private venture studio, we're about putting our money where it matters—in cutting-edge research.
We believe in the world-changing potential of artificial intelligence (AI) across all industries.
It’s about finding effective solutions for a big impact.
Rapid and adaptive—that's our approach.
We believe in the world-changing potential of artificial intelligence (AI) across all industries.
For instance:
We are making significant investments in Al, with a focus on two key areas: utilizing Ocula Al for concussion and impairment, and harnessing Labflow for pathology clinical lab diagnosis.
We firmly believe in harnessing AI to alleviate workloads, leveraging technology that facilitates point-of-care neurological diagnostics, and enhancing clinical AI diagnostic decision-making.
To amplify our research efforts, we have partnered with the University of New South Wales (UNSW) through their LAUNCH program. This collaboration provides us with a dedicated research hub in Canberra, enabling direct collaboration with industry, researchers, and the government.
This is not merely a gamble; we see it as a strategic move toward transformative innovation.
To amplify our research efforts, we have partnered with the University of New South Wales (UNSW) through their LAUNCH program. This collaboration provides us with a dedicated research hub in Canberra, enabling direct collaboration with industry, researchers, and the government.
This is not merely a gamble; we see it as a strategic move toward transformative innovation.